Article
Τumor-informed vs Tumor-naïve
Liquid biopsies are a rapidly evolving diagnostic technology with numerous labs offering commercially available tests today. Most labs have taken an approach of cell-free (cfDNA)
July 3, 2023 10:36 am
Read More »
Innovation
ASCO 23 Posters
GTC presented abstracts at ASCO 2023 GTC’s posters from 2023 Convention of American Society of Clinical Oncology are now available to be downloaded. Please reach
June 8, 2023 11:12 am
Press Releases
Genomic Testing Cooperative Presents at ASCO meeting Studies Demonstrating the Power of its Liquid Biopsy and Tissue-Based Targeted Transcriptomic Approach when Combined with Artificial Intelligence
Irvine, California– May 31, 2023 – Genomic Testing Cooperative, LCA (GTC) announced that it will be presenting at the 2023 American Society of Clinical Oncology
May 31, 2023 4:05 am
Article
New publication on how cfRNA and AI are advancing LBx
GTC has a new publication in Heliyon titled “The Potential of Cell-Free RNA in Liquid Biopsy: Comprehensive Analysis of Mutation Profile, Chromosomal Abnormalities, and Immune
May 23, 2023 11:37 am
Events
Genomics beyond drug selection: Using DNA and RNA data
This workshop is designed for oncologists, pathologists, oncology nurses and other medical professionals involved in patient care for cancer patients. Saturday, September 23 · 7am – 5pm CDT
April 24, 2023 11:15 am
Innovation
AACR 23 Posters
GTC presented abstracts at AACR 2023 GTC’s posters from 2023 Convention of American Association for Cancer Research are now available to be downloaded. Please reach
April 20, 2023 10:49 am
Innovation
Sysmex Inostics and Genomic Testing Cooperative Form Partnership to Accelerate Therapeutic Discovery and Development
Baltimore, MD and Irvine, CA, April 13, 2023, Sysmex Inostics Inc., a subsidiary of Japan’s Sysmex Corporation and Baltimore-based biotechnology firm, and Genomic Testing Cooperative
April 13, 2023 7:00 am
Press Releases
Genomic Testing Cooperative to Present at the AACR 2023 Meeting
Demonstrating Reliability of Targeted Transcriptomic Profiling in Predicting Levels of HER2, ER, PD-L1 and Other Immunohistochemistry-based Biomarkers when Combined with Artificial Intelligence Irvine, California– April
April 11, 2023 4:05 am
Innovation
In Move to Power Precision Oncology for Patients, COTA and Genomic Testing Cooperative Form New Data Partnership
Combining Longitudinal Real-World Data and Clinical Genomics Data Will Enable a More Precise Approach to Cancer Care and Research NEW YORK – COTA, Inc., an
March 8, 2023 5:05 am
Events
ASCO 2023
The 2023 ASCO Annual Meeting Program will offer presentations on the latest research in cancer care. This year’s program will feature over 200 sessions complementing Dr.
January 3, 2023 10:27 am